CytomX Share Price
NASDAQ: CTMX | Micro Cap | HealthcareCytomX Stock Performance
CytomX Share Price Today
As of 19 November 2026, CytomX Therapeutics, Inc.'s share price is $1.93. The stock opened at $2.02, compared to its previous close of $1.95. During today's trading session, CytomX Therapeutics, Inc.'s share price traded between $1.93 and $2.11, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $8.20 and a low of $1.91. In terms of performance, CytomX Therapeutics, Inc.'s share price has declined by 46.38% over the last six months and is down 54.92% on a year-on-year basis.
CytomX Share Price Chart
CytomX Quarterly Profit & Loss
All figures in USD
CytomX Annual Profit & Loss
All figures in USD
CytomX Balance Sheet
All figures in USD Million
CytomX Cash Flow
All figures in USD Million
About CytomX
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
CytomX Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.36 | $1.93 | -18.43% |
Oct 2026 | $2.69 | $2.36 | -13.08% |
Sep 2026 | $3.35 | $2.71 | -20.61% |
Aug 2026 | $3.09 | $3.42 | +10.32% |
Jul 2026 | $3.78 | $3.10 | -17.33% |
Jun 2026 | $3.58 | $3.75 | +4.46% |
May 2026 | $4.25 | $3.59 | -14.83% |
Apr 2026 | $4.73 | $4.21 | -10.32% |
Mar 2026 | $5.29 | $4.70 | -12.23% |
Feb 2026 | $5.63 | $5.36 | -6.05% |
Jan 2026 | $4.27 | $5.70 | +33.18% |
Dec 2025 | $4.13 | $4.28 | +0.23% |